Cleaner Indoor Air for COPD: New Review Maps What Works and What’s Missing

For millions of people living with chronic obstructive pulmonary disease, the most dangerous air they breathe may be inside their own homes. Indoor particulate matter, generated by cooking, heating, tobacco smoke, and the burning of solid fuels, has been shown to accelerate lung function decline, trigger debilitating exacerbations, and raise mortality in COPD patients. Yet while a growing number of interventions promise to clean up the household air of vulnerable patients, the field has lacked any coherent way to organize these efforts or to see where they fall short. A new scoping review published in BMC Public Health by Jiayao Liu, Wanxin Wang, and colleagues at Changzhi Medical College in Shanxi Province, China, now provides exactly that: a systematic classification of indoor particulate matter interventions for COPD patients, mapped onto a well-established environmental health framework that reveals both the strengths and the striking blind spots of current research.

The review, conducted according to the Joanna Briggs Institute scoping review methodology and reported following the PRISMA-ScR checklist, searched ten databases, including PubMed, Embase, Scopus, CINAHL, Web of Science, the Cochrane Library, and four Chinese databases, from their inception to 9 August 2026. Two reviewers independently screened records and charted data using a standardized coding manual, achieving an agreement coefficient of κ = 0.91, a level that indicates near-perfect consistency between the two coders. From this exhaustive search, sixteen studies met the inclusion criteria. The team then classified each intervention by the point in the causal chain at which it primarily acts, using the Driving forces–Pressures–State–Exposure–Effect–Action framework, known as DPSEEA, which environmental health researchers use to organize the pathway from societal drivers of pollution all the way to health effects and back to corrective action.

Three intervention types emerged from the sixteen studies. Air purification dominated the field, appearing in eleven studies. These interventions typically deployed high-efficiency particulate air filtration devices or other purifier technologies to remove particulate matter from the indoor environment after it had already been generated. Multi-component behavioral interventions appeared in five studies, combining elements such as education about pollution sources, guidance on ventilation practices, and encouragement of cleaner cooking or heating behaviors. Policy-level interventions, the least common category, appeared in four studies, encompassing measures such as clean fuel subsidies, improved stove programs, and housing-related regulations that operate far upstream of the individual patient’s living room.

When the researchers located these interventions on the DPSEEA framework, a clear pattern crystallized. Air purification and behavioral interventions both addressed the State and Exposure stages, meaning they acted midway along the causal chain, either by altering the concentration of particulate matter already present in the home or by reducing the contact between the patient and that pollution. The four policy-level interventions, by contrast, acted at the Driving forces and Pressures stages, with two studies each, tackling the societal and structural forces that generate indoor pollution in the first place, such as household energy choices and housing conditions. Most notably, no intervention addressed the Effect stage, and, perhaps more consequentially, no study set out to test coordinated action across multiple stages of the framework.

This absence of coordinated, multi-stage action is the review’s most sobering finding. The DPSEEA framework implies that interventions targeting different points in the causal chain could be complementary: upstream policies that shift households toward cleaner fuels reduce the generation of pollution, while downstream air purifiers and behavioral changes reduce whatever exposure remains. If combining these measures adds benefit beyond either alone, patients would gain the most from integrated programs. But because no study tested such coordination, the existing evidence simply cannot show whether combining upstream and downstream measures adds benefit. The sixteen studies, in other words, describe a field of isolated interventions rather than a system of layered protection.

The outcome measures reported across the studies fell into four broad domains: exposure indicators, which quantify the particulate matter concentrations patients actually experience; clinical and physiological measures, such as forced expiratory volume in one second, the COPD Assessment Test, the St. George’s Respiratory Questionnaire, and the modified Medical Research Council dyspnea scale; health-related quality of life; and behavioral indicators, which track changes in cooking, heating, or ventilation practices. The review found that studies defined these outcomes inconsistently, a technical shortcoming that makes it difficult to pool findings or compare the effectiveness of different intervention types. Without a common set of indicators, the field cannot build a cumulative evidence base in which each new study refines what came before.

The technical logic of the causal chain deserves closer attention, because it explains why the review’s authors frame their conclusions as they do. Particulate matter exposure in COPD follows a pathway: societal driving forces, such as energy poverty and reliance on biomass fuels, create pressures, such as indoor combustion for cooking and heating; these pressures determine the state of the indoor environment, the concentration of particulate matter suspended in household air; the state governs exposure, the amount of pollution inhaled by the patient; and exposure drives effects, the exacerbations, lung function decline, and mortality that define the disease burden. Interventions can, in principle, interrupt this chain at any point. Air purifiers interrupt it late, at the state and exposure stages, and can demonstrably reduce particulate concentrations, but they do nothing about the forces that keep generating pollution. Clean fuel policies interrupt it early, at the driving forces and pressures stages, and are the most likely to be equitable because they change conditions for entire communities rather than for individual households that can afford a purifier.

From this analysis, the review articulates two research priorities. First, upstream policy measures on household energy and housing should be evaluated with health outcomes, since they are the least studied of the intervention types and the most likely to deliver benefits equitably across socioeconomic groups. The authors emphasize that equity-focused research is needed most in low-income, biomass-dependent regions, where solid fuel combustion remains a daily reality for hundreds of millions of households and where the burden of COPD intersects with limited access to clean energy. Second, studies need longer follow-up periods and a common set of outcome indicators. Short follow-up windows cannot capture the slower trajectories of lung function decline or the accumulation of exacerbation risk that matter most to COPD patients, and inconsistent outcome definitions prevent the kind of meta-analytic synthesis that could settle questions about comparative effectiveness.

For COPD patients and their clinicians, the practical takeaway is that air purification currently represents the best-evidenced downstream option, with eleven studies supporting its role in reducing indoor particulate matter exposure, while behavioral counseling on ventilation and fuel use offers a complementary approach that addresses exposure through daily practices. But the review’s framework mapping suggests that patients in biomass-dependent, low-income settings may benefit most from structural changes, such as access to cleaner fuels and improved housing, that no purifier can replicate. For researchers, the message is sharper still: the field needs studies that combine interventions across the DPSEEA stages, evaluate them with harmonized outcomes over clinically meaningful timeframes, and prioritize the populations where indoor air pollution and COPD collide with the least protection. Until such coordinated evidence exists, the promise of cleaner indoor air for COPD patients will remain a collection of partial solutions rather than an integrated public health strategy.

Subject of Research: Indoor particulate matter interventions for COPD: a scoping review mapped onto the DPSEEA framework

Article Title: Interventions to reduce indoor particulate matter exposure in patients with chronic obstructive pulmonary disease: a scoping review

Article References: Liu, J., Wang, W., Hu, X., Xu, J., Chen, F., & Zhao, W. (2026). Interventions to reduce indoor particulate matter exposure in patients with chronic obstructive pulmonary disease: a scoping review. BMC Public Health. https://doi.org/10.1186/s12889-026-29940-3

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29940-3

Keywords: Interventions, reduce, indoor, particulate, matter, exposure, patients, chronic, obstructive, pulmonary, disease, scoping